Crowd tape
Reddit crowd sentimentTracked across the finance subredditsSee the dashboard for live mention data

Equity · Financial Services

MRSH

Marsh & McLennan Companies, Inc. · NYSE

$190 −0.78% 1D Finazon · prior-day close · Jul 31, 2026
Price · Chart
Our own end-of-day closes 26 sessions
$200 $160 25 Jun 31 Jul

The line runs $162 on 25 June through $190 on 31 July, on a scale from $160 to $200. Days the market did not trade hold the previous close, flat.

The chart above plots the price of MRSH over the range selected — one day to the full history — drawn by TradingView from their own data. Our own licensed end-of-day series holds 26 sessions over that window: $162 on 25 June 2026 through $190 on 31 July 2026.

Market cap $90.7B
P/E (TTM) 21.2
52-week range $157 – $197.62
Avg volume 491.8K

Finazon · prior-day close · valuation computed from SEC EDGAR filings · as of Sep 21, 2026

MRSH insider trades

SEC Form 4 · last 90 days · newest reported trade 2 Sep 2026
Open-market buys 0
Open-market sells 6
Net sold $8.21M
Non-trade filings 4
Date Insider Type Shares Value
02 Sep 2026 Brennan Katherine SVP and General Counsel Sell 1,197 $225K
02 Sep 2026 Doyle John Q President and CEO Sell 16,656 $3.14M
06 Aug 2026 Jones John Jude Chief Marketing Officer Sell 6,500 $1.25M
29 Jul 2026 Beswick Paul SVP, Chief Information Officer Sell 713 $141K
28 Jul 2026 South Martin Chief Client Officer Sell 7,100 $1.35M
23 Jul 2026 Yates Lloyd M Director Sell 12,000 $2.11M

Compensation mechanics Share grants, option exercises, tax withholding and transfers. They reach the same Form 4 as a trade, but they are not the insider buying or selling on the open market, so no purchase or sale value applies to them.

Date Insider Type Shares Value
02 Sep 2026 Brennan Katherine SVP and General Counsel Option exercise 1,197 $99K
02 Sep 2026 Doyle John Q President and CEO Option exercise 16,656 $1.22M
15 Aug 2026 BROUSSARD BRUCE D Director Award 192 $36K
15 Aug 2026 MILLS STEVEN A Director Award 194 $37K

MRSH reported financials

SEC EDGAR XBRL

MRSH reported revenue of $27.0B for the fiscal year ended 31 Dec 2025. Net income over the same period was $4.2B.

Figure Reported Period
Revenue $27.0B 31 Dec 2025 fiscal year
Net income $4.2B 31 Dec 2025 fiscal year
Diluted EPS $8.43 31 Dec 2025 fiscal year
Total assets $59.7B 30 Jun 2026 at period end
Total equity incl. minority interest $15.4B 30 Jun 2026 at period end

Source: SEC EDGAR XBRL company facts · latest period ended 30 Jun 2026

MRSH earnings

SEC EDGAR
Date Period EPS Revenue
30 Jun 2026 Q2 2026 $2.63 $7.40B
31 Mar 2026 Q1 2026 $2.36 $7.60B
31 Dec 2025 FY 2025 $8.43 $26.98B
30 Sep 2025 Q3 2025 $1.51 $6.35B
30 Jun 2025 Q2 2025 $2.45 $6.97B
31 Mar 2025 Q1 2025 $2.79 $7.06B
31 Dec 2024 FY 2024 $8.18 $24.46B
30 Sep 2024 Q3 2024 $1.51 $5.70B

Next report no date announced in SEC filings yet

Reported figures & scheduled dates · SEC EDGAR filings

MRSH fails-to-deliver

SEC CNS data

On 26 Aug 2026, 21 shares of MRSH failed to deliver (about $4K).

Settlement date Shares failed Notional % of shares out
26 Aug 2026 21 $4K <0.001%
24 Aug 2026 600 $115K <0.001%
19 Aug 2026 92 $17K <0.001%
12 Aug 2026 2 $383 <0.001%

Source: SEC fails-to-deliver (CNS) data